Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3709411011 | Dabrafenib-containing product in oral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3709412016 | Product containing dabrafenib in oral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dabrafenib-containing product in oral dose form | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Dabrafenib-containing product in oral dose form | Has active ingredient | Dabrafenib | true | Inferred relationship | Some | 1 | |
| Dabrafenib-containing product in oral dose form | Is a | Product manufactured as oral dose form | true | Inferred relationship | Some | ||
| Dabrafenib-containing product in oral dose form | Is a | Dabrafenib-containing product | true | Inferred relationship | Some | ||
| Dabrafenib-containing product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Dabrafenib only product in oral dose form | Is a | True | Dabrafenib-containing product in oral dose form | Inferred relationship | Some | |
| Dabrafenib (as dabrafenib mesylate) 50 mg oral capsule | Is a | False | Dabrafenib-containing product in oral dose form | Inferred relationship | Some | |
| Dabrafenib (as dabrafenib mesylate) 75 mg oral capsule | Is a | False | Dabrafenib-containing product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR